AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7520248 — intervention group
Group type: EXPERIMENTAL
Intervention: Humans immunized with rgp120
Number of subjects: 0
Study 7520248 — intervention group
Group type: EXPERIMENTAL
Intervention: Chimpanzees immunized with rgp120
Number of subjects: 0
Study 2844887 — intervention group
Group type: EXPERIMENTAL
Intervention: Wiping transducers with alcohol between uses
Number of subjects: 2202
Study 2844887 — intervention group
Group type: COMPARATOR
Intervention: Sterilizing with ethylene oxide
Number of subjects: 2202
Study 31919102 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 384
Study 31701652 — intervention group
Group type: EXPERIMENTAL
Intervention: Indocyanine green (ICG) based strategy (SBI)
Number of subjects: 112
Study 31701652 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-drug chemotherapy with lipiodol diameter ratio values between 1 and 3
Number of subjects: 112
Study 31701652 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipiodol ≤10 mL
Number of subjects: 112
Study 31701652 — intervention group
Group type: COMPARATOR
Intervention: SBI (Indocyanine green based strategy)
Number of subjects: 112
Study 29151359 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib (80 mg once daily)
Number of subjects: 556
Study 29151359 — intervention group
Group type: COMPARATOR
Intervention: Standard EGFR-TKIs (gefitinib 250 mg once daily or erlotinib 150 mg once daily)
Number of subjects: 556
Study 25758619 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol vaginal insert (MVI)
Number of subjects: 0
Study 25758619 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone vaginal insert (DVI)
Number of subjects: 0
Study 24486637 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 units of onabotulinum toxin A (Botox A)
Number of subjects: 0
Study 24486637 — intervention group
Group type: COMPARATOR
Intervention: Sacral neuromodulation (InterStim) therapy
Number of subjects: 0
Study 22520521 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 2201
Study 22520521 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (MED)
Number of subjects: 2201
Study 22520521 — intervention group
Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 2201
Study 22520521 — intervention group
Group type: COMPARATOR
Intervention: MED
Number of subjects: 2201
Study 20708427 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand circumference measurement
Number of subjects: 100
Study 20708427 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive regression model based on hand circumference
Number of subjects: 100
Study 17977931 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodyne monochromatic infrared photo energy (MIRE) treatment, used at home every day for 40 min for 90 days.
Number of subjects: 69
Study 17977931 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment, used at home every day for 40 min for 90 days.
Number of subjects: 69
Study 16214012 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg/d)
Number of subjects: 49
Study 16214012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 11523885 — intervention group
Group type: EXPERIMENTAL
Intervention: Cantilever resin‐bonded bridges (RBBs)
Number of subjects: 60
Study 11523885 — intervention group
Group type: COMPARATOR
Intervention: Conventional partial dentures (RPDs)
Number of subjects: 60
Study 9781975 — intervention group
Group type: EXPERIMENTAL
Intervention: trimetazidine (20 mg 3 times daily)
Number of subjects: 15
Study 9781975 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study 7876047 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (IVSK) 1.5 million units within 6 hours of onset of chest pain, along with beta-blockers, aspirin, and heparin unless contraindicated.
Number of subjects: 160
Study 7876047 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy without IVSK.
Number of subjects: 160
Study 2465851 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine and adrenaline combination
Number of subjects: 30
Study 2465851 — intervention group
Group type: COMPARATOR
Intervention: Cocaine alone
Number of subjects: 30
Study 31915181 — intervention group
Group type: EXPERIMENTAL
Intervention: Pare de fumar conosco web-based smoking cessation decision-making tool
Number of subjects: 85
Study 30919670 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (0.1 to 0.2 mg/kg, PO, q 12 h for 7 days)
Number of subjects: 20
Study 30919670 — intervention group
Group type: COMPARATOR
Intervention: Placebo (150 mg of lactose powder in a capsule, PO, q 12 h for 7 days)
Number of subjects: 20
Study 28746195 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial candling treatment
Number of subjects: 66
Study 28746195 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment given)
Number of subjects: 66
Study 26079533 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion at a rate of 2 μg/kg/min until 48 h after surgery
Number of subjects: 36
Study 26079533 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 36
Study 26079533 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 36
Study 23542639 — intervention group
Group type: EXPERIMENTAL
Intervention: NRTI arm (abacavir/zidovudine/lamivudine)
Number of subjects: 54
Study 23542639 — intervention group
Group type: EXPERIMENTAL
Intervention: PI arm (lopinavir/ritonavir/zidovudine/lamivudine)
Number of subjects: 54
Study 23437535 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermally administered inactivated poliovirus vaccine (0.1 mL) using Biojector 2000
Number of subjects: 471
Study 23437535 — intervention group
Group type: COMPARATOR
Intervention: Intramuscularly administered inactivated poliovirus vaccine (0.5 mL) using a pre-filled syringe
Number of subjects: 471
Study 19343272 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg once-weekly
Number of subjects: 560
Study 19343272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 560
Study 16635559 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 16635559 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 0
Study 16635559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15566656 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (GP arm)
Number of subjects: 82
Study 15566656 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine plus vinorelbine (GN arm)
Number of subjects: 82
Study 11584657 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafenoquine
Number of subjects: 411
Study 11584657 — intervention group
Group type: COMPARATOR
Intervention: Primaquine
Number of subjects: 411
Study 9160928 — intervention group
Group type: EXPERIMENTAL
Intervention: KTP laser tonsillectomy
Number of subjects: 38
Study 9160928 — intervention group
Group type: COMPARATOR
Intervention: Standard dissection tonsillectomy
Number of subjects: 38
Study 7955810 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (100 to 150 mg daily for 16 days)
Number of subjects: 8
Study 7955810 — intervention group
Group type: COMPARATOR
Intervention: Control (single oral dose of diazepam 10 mg)
Number of subjects: 8
Study 31359283 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-guided surgery
Number of subjects: 138
Study 31359283 — intervention group
Group type: COMPARATOR
Intervention: Wire-localized surgery
Number of subjects: 138
Study 31359283 — intervention group
Group type: COMPARATOR
Intervention: Mammography
Number of subjects: 138
Study 29570894 — intervention group
Group type: EXPERIMENTAL
Intervention: CTI with concomitant PVI
Number of subjects: 50
Study 29570894 — intervention group
Group type: COMPARATOR
Intervention: CTI-only
Number of subjects: 50
Study 26003419 — intervention group
Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (CBT) for children
Number of subjects: 61
Study 26003419 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CBT for children plus parent training
Number of subjects: 61
Study 26003419 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 61
Study 25283586 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUS
Number of subjects: 44
Study 25283586 — intervention group
Group type: COMPARATOR
Intervention: GnRHa
Number of subjects: 44
Study 22497341 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained cognitive performance
Number of subjects: 29
Study 22497341 — intervention group
Group type: COMPARATOR
Intervention: Cognitively demanding intervention
Number of subjects: 29
Study 19919878 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 20mg twice daily for 14 days, started 24-36 hours after surgery
Number of subjects: 151
Study 19919878 — intervention group
Group type: COMPARATOR
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 151
Study 19919878 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 151
Study 19919878 — intervention group
Group type: COMPARATOR
Intervention: IPC
Number of subjects: 151
Study 18990744 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g GTE per day for 12 months
Number of subjects: 136
Study 18990744 — intervention group
Group type: COMPARATOR
Intervention: Control group without supplementation
Number of subjects: 136
Study 16465662 — intervention group
Group type: EXPERIMENTAL
Intervention: Seal oil
Number of subjects: 43
Study 16465662 — intervention group
Group type: COMPARATOR
Intervention: Soy oil
Number of subjects: 43
Study 12809189 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety Management group received training on relaxation strategies (deep breathing, progressive muscle relaxation)
Number of subjects: 0
Study 12809189 — intervention group
Group type: COMPARATOR
Intervention: Attention Control group attended a lecture on the relation among stress, anxiety, and health
Number of subjects: 0
Study 11232889 — intervention group
Group type: EXPERIMENTAL
Intervention: C-arm-supported CT fluoroscopy
Number of subjects: 40
Study 11232889 — intervention group
Group type: COMPARATOR
Intervention: CT fluoroscopy alone
Number of subjects: 40
Study 8857072 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 200 mg b.d. for 14 days
Number of subjects: 24
Study 8857072 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline 5 mg b.d. for 14 days
Number of subjects: 24
Study 8857072 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with moclobemide and selegiline
Number of subjects: 24
Study 1352497 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (highly lipophilic BAA, no PAA)
Number of subjects: 12
Study 1352497 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol (moderately lipophilic BAA, strong PAA)
Number of subjects: 12
Study 1352497 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilevalol (highly lipophilic BAA, weak PAA)
Number of subjects: 12
Study 1352497 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (full agonist)
Number of subjects: 12
Study 1352497 — intervention group
Group type: EXPERIMENTAL
Intervention: BAAs with PAA
Number of subjects: 12
Study 6391231 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of clindamycin and tobramycin
Number of subjects: 0
Study 6391231 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole or cefoxitin
Number of subjects: 0
Study 6391231 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 0
Study 6391231 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobramycin plus clindamycin
Number of subjects: 0
Study 30153781 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol-guided strategy using stroke volume variation to guide administration of bolus fluid
Number of subjects: 700
Study 30153781 — intervention group
Group type: COMPARATOR
Intervention: Usual care fluid administration
Number of subjects: 700
Study 27128738 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelican instrument for asthma management
Number of subjects: 42
Study 27128738 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent and nurse satisfaction with the program
Number of subjects: 42
Study 27128738 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART principles for goal formulation
Number of subjects: 42
Study 27128738 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional management aspects
Number of subjects: 42
Study 24783923 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized treatment with TCM combined with WM (oral Chinese decoctions three times daily for 4 weeks)
Number of subjects: 90
Study 24783923 — intervention group
Group type: COMPARATOR
Intervention: Non-standardized treatment with TCM combined with WM (oral Chinese decoction for promotion of blood circulation for 4 weeks)
Number of subjects: 90
Study 24783923 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (standardized and non-standardized treatment)
Number of subjects: 90
Study 21801088 — intervention group
Group type: EXPERIMENTAL
Intervention: Lip adhesion
Number of subjects: 53
Study 21801088 — intervention group
Group type: EXPERIMENTAL
Intervention: H (‐) group (no Hotz's plate)
Number of subjects: 53
Study 21801088 — intervention group
Group type: EXPERIMENTAL
Intervention: H (+) group (with Hotz's plate)
Number of subjects: 53
Study 21801088 — intervention group
Group type: EXPERIMENTAL
Intervention: LA‐H group (lip adhesion and Hotz's plate)
Number of subjects: 53
Study 21801088 — intervention group
Group type: COMPARATOR
Intervention: Noncleft group
Number of subjects: 53
Study 19347843 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly active antiretroviral therapy (ART)
Number of subjects: 1156
Study 19347843 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncompliance correction using inverse probability-of-censoring weights
Number of subjects: 1156
Study 17447222 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconcile (fluoxetine, 1 to 2 mg/kg/day) plus behavior management
Number of subjects: 0
Study 14716221 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of low-dose nifedipine GITS 20 mg and losartan 50 mg
Number of subjects: 300
Study 14716221 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg
Number of subjects: 300
Study 14716221 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine GITS 20 mg
Number of subjects: 300
Study 12635758 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracervical block with 1% lignocaine
Number of subjects: 142
Study 12635758 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (paracervical block with sterile water)
Number of subjects: 142
Study 9855086 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole infusion (80 mg + 8 mg/h) for 24 hours followed by 8, 4 or 2 mg/h.
Number of subjects: 24
Study 9855086 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous omeprazole infusion (80 mg + 8 mg/h) for 3 days followed by oral omeprazole 20 mg once daily.
Number of subjects: 24
Study 7584296 — intervention group
Group type: EXPERIMENTAL
Intervention: Recall and recognition tasks with varying word frequency
Number of subjects: 0
Study 7584296 — intervention group
Group type: EXPERIMENTAL
Intervention: Position judgements about list items
Number of subjects: 0
Study 2607520 — intervention group
Group type: EXPERIMENTAL
Intervention: Accutracker blood pressure monitor
Number of subjects: 14
Study 977834 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded speech samples from speakers (30 speakers total, 15 males and 15 females)
Number of subjects: 30
Study 30727981 — intervention group
Group type: EXPERIMENTAL
Intervention: REPRINTS intergenerational health promotion program
Number of subjects: 891
Study 30727981 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals aged 30-59 and over 60 years
Number of subjects: 891
Study 28263212 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel (4 cycles of 25 mg/m2 + 2 cycles of 20 mg/m2) combined with 188Re-HEDP (40 MBq/kg)
Number of subjects: 12
Study 28263212 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabazitaxel (6 cycles of 25 mg/m2) combined with 188Re-HEDP (40 MBq/kg)
Number of subjects: 12
Study 28263212 — intervention group
Group type: COMPARATOR
Intervention: Cabazitaxel monotherapy
Number of subjects: 12
Study 26497995 — intervention group
Group type: EXPERIMENTAL
Intervention: HALP ≥ 56.8
Number of subjects: 1332
Study 26497995 — intervention group
Group type: COMPARATOR
Intervention: HALP < 56.8
Number of subjects: 1332
Study 24079100 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth ultrasonic debridement (FMUD) for smokers (n = 10)
Number of subjects: 30
Study 24079100 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) for smokers (n = 10)
Number of subjects: 30
Study 24079100 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) for non-smokers (n = 10)
Number of subjects: 30
Study 21525848 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs) administered orally on single days to assess immediate effects on motor function.
Number of subjects: 0
Study 19663371 — intervention group
Group type: EXPERIMENTAL
Intervention: Gore-Tex thyroplasty
Number of subjects: 30
Study 19663371 — intervention group
Group type: COMPARATOR
Intervention: Silicone thyroplasty
Number of subjects: 30
Study 16339819 — intervention group
Group type: EXPERIMENTAL
Intervention: Enrasentan (60‐90 mg/day)
Number of subjects: 72
Study 16339819 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (10‐20 mg/day)
Number of subjects: 72
Study 14724371 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle modification (ILM) program including dietary advice on low-fat diets, high antioxidants and high fiber intakes, yoga exercise, stress management and smoking cessation for 4 months.
Number of subjects: 44
Study 14724371 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with lipid-lowering drugs (control group).
Number of subjects: 44
Study 10735925 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, amoxycillin, clarithromycin for 7 days
Number of subjects: 90
Study 10735925 — intervention group
Group type: COMPARATOR
Intervention: Placebo (omeprazole and placebos for 7 days)
Number of subjects: 90
Study 10735925 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, amoxycillin, clarithromycin
Number of subjects: 90
Study 10735925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 8766460 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling intervention (6 weekly sessions, educational and problem-solving components, conducted in the family home)
Number of subjects: 63
Study 8766460 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling intervention
Number of subjects: 63
Study 8766460 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 63
Study 1417023 — intervention group
Group type: EXPERIMENTAL
Intervention: Copolymer of polyurethane membrane dressing
Number of subjects: 5
Study 1417023 — intervention group
Group type: COMPARATOR
Intervention: Commercially available adhesive bandages
Number of subjects: 5
Study 3921583 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined enteral-parenteral nutrition (CN)
Number of subjects: 20
Study 3921583 — intervention group
Group type: COMPARATOR
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 20
Study 30575059 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 20
Study 30575059 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic scaler (US)
Number of subjects: 20
Study 30547287 — intervention group
Group type: EXPERIMENTAL
Intervention: MCAF5352A (humanized monoclonal antibody targeting IL-17A and IL-17F)
Number of subjects: 0
Study 27442130 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical bromfenac
Number of subjects: 65
Study 27442130 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 25124078 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz
Number of subjects: 325
Study 25124078 — intervention group
Group type: EXPERIMENTAL
Intervention: lower cost of clinic visits
Number of subjects: 325
Study 25124078 — intervention group
Group type: EXPERIMENTAL
Intervention: improvement in CD4 percentage
Number of subjects: 325
Study 25124078 — intervention group
Group type: EXPERIMENTAL
Intervention: care at Kayunga vs. Kangulamira
Number of subjects: 325
Study 25124078 — intervention group
Group type: EXPERIMENTAL
Intervention: time on ART
Number of subjects: 325
Study 25124078 — intervention group
Group type: EXPERIMENTAL
Intervention: patient satisfaction with care
Number of subjects: 325
Study 25124078 — intervention group
Group type: EXPERIMENTAL
Intervention: improvements in total lymphocyte count
Number of subjects: 325
Study 25124078 — intervention group
Group type: EXPERIMENTAL
Intervention: haemoglobin concentration
Number of subjects: 325
Study 25124078 — intervention group
Group type: EXPERIMENTAL
Intervention: age at start of ART
Number of subjects: 325
Study 23254183 — intervention group
Group type: COMPARATOR
Intervention: Family meals (always eating together at a table)
Number of subjects: 2383
Study 23254183 — intervention group
Group type: COMPARATOR
Intervention: Daily consumption of F&V by parents
Number of subjects: 2383
Study 23254183 — intervention group
Group type: COMPARATOR
Intervention: Cutting up fruit and vegetables for children
Number of subjects: 2383
Study 21574683 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual-guided treatment
Number of subjects: 76
Study 21574683 — intervention group
Group type: COMPARATOR
Intervention: Usual care (nonmanualized treatment)
Number of subjects: 76
Study 18050382 — intervention group
Group type: EXPERIMENTAL
Intervention: CF101 1.0 mg bid for 12 weeks
Number of subjects: 74
Study 18050382 — intervention group
Group type: EXPERIMENTAL
Intervention: CF101 0.1 mg bid for 12 weeks
Number of subjects: 74
Study 18050382 — intervention group
Group type: EXPERIMENTAL
Intervention: CF101 4.0 mg bid for 12 weeks
Number of subjects: 74
Study 18050382 — intervention group
Group type: EXPERIMENTAL
Intervention: CF101 (all doses)
Number of subjects: 74
Study 18050382 — intervention group
Group type: EXPERIMENTAL
Intervention: A3AR expression levels
Number of subjects: 74
Study 16681980 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy and radiotherapy concurrently
Number of subjects: 40
Study 16681980 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant thermotherapy and radiotherapy sequentially
Number of subjects: 40
Study 12959789 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 100